Status:
COMPLETED
Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Conditions:
Bladder Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This is a two-arm, randomized-controlled pilot study with 2 year duration. The "intervention" refers to surveillance based on the European Association of Urology (EAU) guidelines and the "control" ref...
Detailed Description
This is a two-arm, randomized-controlled pilot study with 2 year duration. The "intervention" refers to surveillance based on the EAU guidelines and the "control" refers to surveillance based on the A...
Eligibility Criteria
Inclusion
- Must have non-muscle invasive low-grade, papillary (Ta) bladder cancer.
- Must have a negative cystoscopy following most recent biopsy.
- Must be able to give informed consent.
- Must be age 18 or older.
- Must be at low- or low-intermediate risk for disease recurrence and progression according to the EAU guidelines.
Exclusion
- Have a history of invasive (\>=T1) bladder cancer.
- Have a history of carcinoma-in-situ (CIS).
- Unable to give informed consent.
- \< 18 or younger.
- Variant histology (micropapillary, nested variant, non-urothelial cell carcinoma elements).
- Had a surveillance cystoscopy following most recent biopsy.
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 7 2021
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT02298998
Start Date
March 1 2013
End Date
June 7 2021
Last Update
June 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas Health Science Center
San Antonio, Texas, United States, 78229